Analysis of Liquidity Ratios
Quarterly Data
Liquidity ratios measure the company ability to meet its short-term obligations.
Liquidity Ratios (Summary)
UnitedHealth Group Inc., liquidity ratios (quarterly data)
Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).
The liquidity position, as indicated by the current, quick, and cash ratios, exhibits a generally stable pattern with some fluctuations over the observed period. Throughout 2022 and the first half of 2023, the ratios remained relatively consistent, followed by a period of modest improvement and subsequent stabilization, and a slight decline towards the end of the period.
- Current Ratio
- The current ratio fluctuated between 0.77 and 0.82 during 2022. A slight upward trend was observed in the first half of 2023, peaking at 0.88 in June 2024, before decreasing to 0.79 by December 2025. The ratio generally remained below 0.9, suggesting a limited margin of safety in covering short-term liabilities with short-term assets.
- Quick Ratio
- The quick ratio followed a similar pattern to the current ratio, ranging from 0.70 to 0.83. It demonstrated a slight increase through June 2024, reaching 0.83, and then decreased to 0.70 by December 2025. The quick ratio consistently remained above 0.7, indicating a reasonable ability to meet immediate obligations with its most liquid assets. However, the difference between the current and quick ratios suggests that inventory comprises a notable portion of current assets.
- Cash Ratio
- The cash ratio exhibited the most pronounced fluctuations, ranging from 0.24 to 0.46. It peaked at 0.46 in September 2022, then generally trended downward, reaching 0.24 in December 2025. This indicates a relatively conservative liquidity position, with a smaller proportion of current assets held in cash and cash equivalents. The decline suggests a potential shift in asset allocation or increased investment in less liquid assets.
Overall, the observed liquidity ratios suggest a consistent, though somewhat constrained, ability to meet short-term obligations. The slight improvements observed in 2024 were followed by a modest decline in the final periods, warranting continued monitoring to ensure sufficient liquidity is maintained.
AI Ask an analyst for more
Current Ratio
UnitedHealth Group Inc., current ratio calculation (quarterly data)
| Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||
| Current assets | 90,582) | 95,067) | 93,699) | 96,285) | 85,779) | 92,258) | 92,038) | 88,942) | 78,437) | 91,905) | 89,869) | 93,895) | 69,069) | 82,937) | 68,356) | 69,029) | |||||
| Current liabilities | 114,897) | 115,526) | 110,781) | 113,471) | 103,769) | 101,565) | 104,670) | 104,431) | 99,054) | 114,179) | 112,981) | 116,482) | 89,237) | 100,935) | 88,698) | 88,170) | |||||
| Liquidity Ratio | |||||||||||||||||||||
| Current ratio1 | 0.79 | 0.82 | 0.85 | 0.85 | 0.83 | 0.91 | 0.88 | 0.85 | 0.79 | 0.80 | 0.80 | 0.81 | 0.77 | 0.82 | 0.77 | 0.78 | |||||
| Benchmarks | |||||||||||||||||||||
| Current Ratio, Competitors2 | |||||||||||||||||||||
| Abbott Laboratories | 1.58 | 1.70 | 1.82 | 1.78 | 1.67 | 1.60 | 1.68 | 1.60 | 1.64 | 1.74 | 1.64 | 1.68 | 1.63 | 1.86 | 2.01 | 1.85 | |||||
| Elevance Health Inc. | 1.54 | 1.56 | 1.44 | 1.43 | 1.45 | 1.50 | 1.49 | 1.37 | 1.44 | 1.41 | 1.44 | 1.43 | 1.40 | 1.35 | 1.36 | 1.36 | |||||
| Intuitive Surgical Inc. | 4.87 | 4.73 | 5.17 | 4.98 | 4.07 | 4.30 | 5.15 | 5.55 | 4.76 | 5.31 | 5.22 | 5.26 | 4.40 | 5.10 | 5.36 | 5.22 | |||||
| Medtronic PLC | 1.85 | 1.90 | 1.84 | 2.13 | 2.03 | 2.30 | 2.29 | 2.42 | 2.39 | 1.76 | 1.76 | 1.58 | 1.86 | 2.61 | 2.91 | 2.89 | |||||
Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).
1 Q4 2025 Calculation
Current ratio = Current assets ÷ Current liabilities
= 90,582 ÷ 114,897 = 0.79
2 Click competitor name to see calculations.
The current ratio exhibits a generally stable pattern over the observed period, with fluctuations occurring throughout the quarters. Initial values indicate a ratio below 0.80 for the first four quarters, ranging from 0.77 to 0.78. A slight improvement is then noted, with the ratio increasing to 0.81 in the first quarter of 2023.
- Overall Trend
- The current ratio demonstrates a modest upward trend from 2022 through the first half of 2024, peaking at 0.91 in the third quarter of 2024. However, this is followed by a decline in the latter half of 2024 and into 2025, returning to levels comparable to those observed in 2022 and 2023.
- Short-Term Fluctuations
- A noticeable increase in the current ratio is observed between the fourth quarter of 2023 (0.79) and the second quarter of 2024 (0.88). This suggests an improvement in the company’s ability to cover its short-term liabilities with its short-term assets during this period. Conversely, a decrease is apparent from the third quarter of 2024 (0.91) through the second quarter of 2025 (0.85).
- Recent Performance
- The most recent quarters show a slight downward adjustment in the current ratio. The ratio decreased from 0.85 in the first quarter of 2025 to 0.79 in the fourth quarter of 2025. This suggests a potential weakening in short-term liquidity, although the ratio remains within a relatively narrow range observed throughout the analyzed timeframe.
The current ratio consistently remains below 1.0 throughout the entire period. While not necessarily indicative of immediate financial distress, it suggests that the entity’s current liabilities exceed its current assets at any given point in time. The observed fluctuations warrant continued monitoring to assess any potential impact on the company’s short-term financial health.
AI Ask an analyst for more
Quick Ratio
UnitedHealth Group Inc., quick ratio calculation (quarterly data)
| Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||
| Cash and cash equivalents | 24,365) | 27,210) | 28,596) | 30,717) | 25,312) | 32,400) | 26,286) | 28,414) | 25,427) | 38,915) | 41,813) | 41,913) | 23,365) | 38,845) | 24,612) | 25,482) | |||||
| Short-term investments | 3,756) | 3,404) | 3,424) | 3,574) | 3,801) | 4,734) | 5,037) | 4,296) | 4,201) | 5,182) | 4,466) | 4,584) | 4,546) | 3,682) | 3,352) | 2,914) | |||||
| Accounts receivable, net | 23,018) | 22,672) | 24,142) | 26,936) | 22,365) | 20,024) | 23,115) | 27,197) | 21,276) | 20,673) | 17,952) | 22,414) | 17,681) | 17,047) | 18,718) | 18,871) | |||||
| Other current receivables, net | 29,697) | 32,762) | 28,582) | 26,022) | 26,089) | 27,461) | 26,762) | 19,284) | 17,694) | 17,752) | 16,131) | 14,696) | 12,769) | 13,684) | 12,439) | 11,994) | |||||
| Assets under management | —) | —) | —) | —) | —) | —) | 3,414) | 3,619) | 3,755) | 3,616) | 3,623) | 3,837) | 4,087) | 4,022) | 4,017) | 4,155) | |||||
| Total quick assets | 80,836) | 86,048) | 84,744) | 87,249) | 77,567) | 84,619) | 84,614) | 82,810) | 72,353) | 86,138) | 83,985) | 87,444) | 62,448) | 77,280) | 63,138) | 63,416) | |||||
| Current liabilities | 114,897) | 115,526) | 110,781) | 113,471) | 103,769) | 101,565) | 104,670) | 104,431) | 99,054) | 114,179) | 112,981) | 116,482) | 89,237) | 100,935) | 88,698) | 88,170) | |||||
| Liquidity Ratio | |||||||||||||||||||||
| Quick ratio1 | 0.70 | 0.74 | 0.76 | 0.77 | 0.75 | 0.83 | 0.81 | 0.79 | 0.73 | 0.75 | 0.74 | 0.75 | 0.70 | 0.77 | 0.71 | 0.72 | |||||
| Benchmarks | |||||||||||||||||||||
| Quick Ratio, Competitors2 | |||||||||||||||||||||
| Abbott Laboratories | 1.02 | 1.09 | 1.14 | 1.09 | 1.05 | 1.00 | 1.02 | 0.95 | 1.00 | 1.04 | 1.00 | 1.07 | 1.06 | 1.22 | 1.33 | 1.21 | |||||
| Elevance Health Inc. | 1.41 | 1.43 | 1.32 | 1.31 | 1.32 | 1.34 | 1.32 | 1.23 | 1.30 | 1.29 | 1.32 | 1.31 | 1.27 | 1.21 | 1.22 | 1.23 | |||||
| Intuitive Surgical Inc. | 3.72 | 3.42 | 3.90 | 3.73 | 3.00 | 3.21 | 3.94 | 4.31 | 3.83 | 4.44 | 4.36 | 4.30 | 3.56 | 4.19 | 4.49 | 4.40 | |||||
| Medtronic PLC | 1.20 | 1.19 | 1.17 | 1.35 | 1.31 | 1.46 | 1.42 | 1.51 | 1.54 | 1.18 | 1.18 | 1.01 | 1.30 | 1.87 | 2.07 | 2.06 | |||||
Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).
1 Q4 2025 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 80,836 ÷ 114,897 = 0.70
2 Click competitor name to see calculations.
The quick ratio for the analyzed period demonstrates a generally stable pattern with moderate fluctuations. Throughout the observed timeframe, the ratio consistently remains above 0.70, suggesting a reasonable capacity to meet short-term obligations with highly liquid assets.
- Overall Trend
- The quick ratio exhibits a slight upward trend over the period, beginning at 0.72 and reaching a peak of 0.83 before declining to 0.70. This suggests a gradual improvement in the company’s ability to cover immediate liabilities with its most liquid assets, followed by a recent moderation.
- Quarterly Fluctuations
- A noticeable increase in the quick ratio is observed between March 31, 2022 (0.72) and September 30, 2022 (0.77). A subsequent decrease to 0.70 is then seen by December 31, 2022. The ratio then increases significantly to 0.75 by March 31, 2023, and remains relatively stable through September 30, 2023. A further increase to 0.83 is observed by June 30, 2024, representing the highest point in the analyzed period. The ratio then declines to 0.70 by December 31, 2025.
- Asset and Liability Relationship
- The quick ratio’s fluctuations correlate with changes in both quick assets and current liabilities. Increases in the ratio generally coincide with larger increases in quick assets relative to current liabilities, while decreases occur when current liabilities grow at a faster rate than quick assets. The observed decline in the ratio towards the end of the period is primarily driven by a decrease in quick assets, while current liabilities remain relatively stable.
In conclusion, the quick ratio indicates a generally healthy liquidity position. While fluctuations exist, the ratio consistently remains within an acceptable range, suggesting the company maintains sufficient liquid assets to address its short-term obligations. The recent decline warrants monitoring to ensure it does not indicate a developing trend of weakening liquidity.
AI Ask an analyst for more
Cash Ratio
UnitedHealth Group Inc., cash ratio calculation (quarterly data)
| Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||
| Cash and cash equivalents | 24,365) | 27,210) | 28,596) | 30,717) | 25,312) | 32,400) | 26,286) | 28,414) | 25,427) | 38,915) | 41,813) | 41,913) | 23,365) | 38,845) | 24,612) | 25,482) | |||||
| Short-term investments | 3,756) | 3,404) | 3,424) | 3,574) | 3,801) | 4,734) | 5,037) | 4,296) | 4,201) | 5,182) | 4,466) | 4,584) | 4,546) | 3,682) | 3,352) | 2,914) | |||||
| Assets under management | —) | —) | —) | —) | —) | —) | 3,414) | 3,619) | 3,755) | 3,616) | 3,623) | 3,837) | 4,087) | 4,022) | 4,017) | 4,155) | |||||
| Total cash assets | 28,121) | 30,614) | 32,020) | 34,291) | 29,113) | 37,134) | 34,737) | 36,329) | 33,383) | 47,713) | 49,902) | 50,334) | 31,998) | 46,549) | 31,981) | 32,551) | |||||
| Current liabilities | 114,897) | 115,526) | 110,781) | 113,471) | 103,769) | 101,565) | 104,670) | 104,431) | 99,054) | 114,179) | 112,981) | 116,482) | 89,237) | 100,935) | 88,698) | 88,170) | |||||
| Liquidity Ratio | |||||||||||||||||||||
| Cash ratio1 | 0.24 | 0.26 | 0.29 | 0.30 | 0.28 | 0.37 | 0.33 | 0.35 | 0.34 | 0.42 | 0.44 | 0.43 | 0.36 | 0.46 | 0.36 | 0.37 | |||||
| Benchmarks | |||||||||||||||||||||
| Cash Ratio, Competitors2 | |||||||||||||||||||||
| Abbott Laboratories | 0.54 | 0.53 | 0.54 | 0.53 | 0.56 | 0.52 | 0.52 | 0.47 | 0.53 | 0.54 | 0.57 | 0.66 | 0.66 | 0.74 | 0.75 | 0.65 | |||||
| Elevance Health Inc. | 0.88 | 0.89 | 0.79 | 0.79 | 0.85 | 0.90 | 0.86 | 0.82 | 0.87 | 0.90 | 0.92 | 0.91 | 0.86 | 0.87 | 0.86 | 0.86 | |||||
| Intuitive Surgical Inc. | 2.96 | 2.72 | 3.15 | 2.93 | 2.30 | 2.52 | 3.20 | 3.49 | 3.15 | 3.86 | 3.77 | 3.59 | 2.90 | 3.50 | 3.78 | 3.58 | |||||
| Medtronic PLC | 0.70 | 0.67 | 0.66 | 0.76 | 0.74 | 0.85 | 0.80 | 0.87 | 0.88 | 0.77 | 0.79 | 0.63 | 0.85 | 1.26 | 1.37 | 1.36 | |||||
Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).
1 Q4 2025 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 28,121 ÷ 114,897 = 0.24
2 Click competitor name to see calculations.
The cash ratio for the analyzed period demonstrates fluctuations, generally exhibiting a moderate level of liquidity. Initial values indicate a ratio around 0.36 to 0.37 in the first four quarters of the period. A subsequent increase is observed, peaking at 0.46 before declining again.
- Overall Trend
- The cash ratio generally decreased over the observed timeframe. While there were periods of improvement, the ratio concluded the period at its lowest point, 0.24. This suggests a potential weakening in the company’s immediate ability to meet its current obligations with only cash and cash equivalents.
- Initial Period (Mar 31, 2022 – Dec 31, 2022)
- The cash ratio remained relatively stable, fluctuating between 0.36 and 0.46. This indicates a consistent, though not exceptionally strong, capacity to cover short-term liabilities with available cash. The peak of 0.46 in September 2022 represents the highest liquidity position within this timeframe.
- Subsequent Period (Mar 31, 2023 – Dec 31, 2025)
- Following the initial period, a gradual downward trend in the cash ratio becomes apparent. The ratio decreased from 0.43 in March 2023 to 0.24 in December 2025. This decline suggests a potential shift in the company’s liquidity management or an increase in short-term obligations relative to its cash holdings. The most significant decrease occurred between September 2024 and December 2025.
- Total Cash Assets & Current Liabilities Relationship
- While total cash assets experienced fluctuations, the increase in current liabilities appears to be a primary driver of the declining cash ratio. Current liabilities consistently remained substantial, and their growth, particularly from March 2023 onwards, outpaced the changes in total cash assets, contributing to the observed decrease in the ratio.
In conclusion, the cash ratio indicates a diminishing capacity to cover immediate liabilities with cash. Continued monitoring of this ratio, alongside other liquidity metrics, is recommended to assess the company’s ongoing financial health and potential risks.
AI Ask an analyst for more